Lipella Pharmaceuticals Inc.
OTC: LIPO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jonathan Kaufman
- Employees
- 5
- Headquarters
- Pittsburgh, United States
- IPO year
- 2022
- Market cap
- $383.5K
- Website
- https://www.lipella.com
Loading LIPO…
Loading profile data…Frequently asked questions about LIPO
What does Lipella Pharmaceuticals Inc. (LIPO) do?
Lipella Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm specializing in the creation of novel therapies. The company achieves this by repurposing and optimizing the active ingredients found in established generic drugs, tailoring these reformulations for diverse medical applications. Its lead candidate, LP-10, a tacrolimus formul...
Where does LIPO trade?
Lipella Pharmaceuticals Inc. (LIPO) trades on the Other OTC.
What sector is LIPO in?
Lipella Pharmaceuticals Inc. (LIPO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Lipella Pharmaceuticals Inc.?
Jonathan Kaufman is the chief executive officer of Lipella Pharmaceuticals Inc. (LIPO).
Where is Lipella Pharmaceuticals Inc. headquartered?
Lipella Pharmaceuticals Inc. is headquartered in United States.
Does LIPO pay a dividend?
Lipella Pharmaceuticals Inc. (LIPO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LIPO go public?
Lipella Pharmaceuticals Inc. (LIPO) completed its initial public offering in 2022.